• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number ESP200-21
Medical Device Problem Code Intravalvular regurgitation (4068)
Health Effect - Clinical Codes Angina (1710); Aortic Valve Insufficiency/ Regurgitation (4450)
Date of Event 08/06/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that on (b)(6) 2025, the patient underwent aortic valve replacement (avr) procedure with a 21mm epic plus supra valve and coronary artery bypass graft surgery (cabg).The annular diameter of the native valve was 21mm.Immediate post-operative, the patient had exertional angina and transesophageal echocardiogram (tee) showed mild aortic regurgitation (ar).On (b)(6) 2025, tte demonstrated progression to moderate ar.Subsequent tte performed on (b)(6) 2025 confirmed moderately severe ar (3+) with stable hemodynamics.There was no intervention performed for mid aortic regurgitation (ar).The patient was reported stable and discharged.
 
Additional Manufacturer Narrative
The device remains implanted in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of central regurgitation and aortic valve regurgitation was reported.A returned device inspection could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.The investigation was unable to determine the cause of the reported central regurgitation, aortic valve regurgitation, and angina.The reported serious injury/illness/impairment was a result of case-specific circumstances.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Event or Problem Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ SUPRA VALVE (AORTIC)
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL LTDA. REG#3001883144
1301rua profvieira demendonça
bairro engenho nogueira 31.31 0-26
BR   31.310-260
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key23184128
Report Number2135147-2025-05531
Device Sequence Number21330105
Product Code LWR
UDI-Device Identifier05415067033123
UDI-Public(01)05415067033123(17)290401
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
P040021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/30/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberESP200-21
Device Catalogue NumberESP200-21
Device Lot NumberBR00051848
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/05/2025
Supplement Date Received by Manufacturer12/16/2025
Initial Report FDA Received Date09/30/2025
Supplement Report FDA Received Date12/30/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/02/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age68 YR
Patient SexMale
-
-